Latest Updates

On April 8th the U.S. Department of Health and Human Services (HHS) made the historic decision to allow pharmacists to order and administer FDA approved COVID-19 tests. Empowering pharmacists to test for COVID-19 is a policy GNP and ABC have advocated for, and we are pleased to see this recent HHS guidance. However, in California pharmacists are still unable to administer COVID-19 tests due to existing state restrictions.

On April 8th the U.S. Department of Health and Human Services (HHS) made the historic decision to allow pharmacists to order and administer FDA approved COVID-19 tests. Empowering pharmacists to test for COVID-19 is a policy GNP and ABC have advocated for, and we are pleased to see this recent HHS guidance. However, in New York pharmacists are still unable to administer COVID-19 tests due to existing state restrictions.

Please contact your representative today to encourage them to sign onto a bipartisan letter to Congressional Leadership calling for the inclusion of pharmacy DIR fee relief in the next COVID-19 legislative package. Visit NCPA’s legislative action center at this link to contact your representative today!

The U.S. Supreme Court is postponing April oral arguments in accordance to public health guidance in response to COVID-19. The postponement includes Rutledge v. PCMA, the landmark case on whether states can adopt meaningful regulations on PBMs.

Long-term care is an often-overlooked part of the health care system, but evolving demographics in the United States have put a renewed focus on this segment, and the overall market is on the precipice of significant change. Life expectancy is rising and people are increasingly seeking care, such as skilled nursing and assisted living facilities, for either themselves or their aging parents.